FDA Cracks Down on Copycat Drug Market Amid Hims Controversy
Published on: Feb. 6, 2026, 7:46 a.m. | Source: Devdiscourse
The FDA is set to take action against companies selling unapproved copycat drugs, as seen in the case of Hims and Hers Health marketing a cheaper version of Novo Nordisk's Wegovy weight-loss pill. The compounded drug lacks FDA approval, raising concerns about safety and efficacy.
